Eltagonde, Rowena C.

HRN: 10-89-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2024
CEFTRIAXONE 1G (VIAL)
11/09/2024
11/16/2024
IV
2g
OD
Avulsed Woubd
Waiting Final Action 
11/10/2024
CLINDAMYCIN 300MG (CAP)
11/10/2024
11/17/2024
PO
300 Mg
TID
Avulsed Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: